FIREFLY NEUROSCIENCE, INC. AIFF Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2
adsh 0001437749-25-016587 0001437749-25-010818
cik 803578 803578
name FIREFLY NEUROSCIENCE, INC. FIREFLY NEUROSCIENCE, INC.
sic 7372 7372
countryba US US
stprba NY NY
cityba KENMORE KENMORE
zipba 14217 14217
bas1 1100 MILITARY ROAD 1100 MILITARY ROAD
bas2
baph 888-237-6412 888-237-6412
countryma US US
stprma NY NY
cityma KENMORE KENMORE
zipma 14217 14217
mas1 1100 MILITARY ROAD 1100 MILITARY ROAD
mas2
countryinc US US
stprinc DE DE
ein 541167364 541167364
former WAVEDANCER, INC. WAVEDANCER, INC.
changed 20211215 20211215
afs 4-NON 4-NON
wksi 0 0
fye 1231 1231
form 10-Q 10-K
period 20250331 20241231
fy 2025 2024
fp Q1 FY
filed 20250514 20250403
accepted 2025-05-14 06:02:00.0 2025-04-03 06:02:00.0
prevrpt 0 0
detail 1 1
instance wavd20250331_10q_htm.xml wavd20241231c_10k_htm.xml
nciks 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001437749-25-016587 20250331 Accounts Payable Current 1612000.0000 USD 0 us-gaap/2025
0001437749-25-010818 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001437749-25-010818 20240731 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= New Firefly Common Stock;
0001437749-25-010818 20231231 Common Stock Shares Authorized 258880000.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Common Stock Shares Outstanding 8122060.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Contract With Customer Liability Current 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Convertible Debt Current 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Convertible Debt Current 694000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Debt Conversion Converted Instrument Amount1 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock;
0001437749-25-010818 20241231 Deemed Issuance Of Common Shares 204000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20241231 Earnings Per Share Basic -1.6000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Interest And Bank Fees 0.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20241231 Interest And Bank Fees 30000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Investment Income Net -18000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Issuance Of Stock And Warrants For Services Or Claims 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Cash Provided By Used In Investing Activities -386000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20231231 Payments For Product Enhancements 386000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Preferred Stock Shares Issued 1676165.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Prepaid Expense And Other Assets Noncurrent 1657000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Research And Development Expense 741000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Retained Earnings Accumulated Deficit -87084000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Share Based Compensation 2594000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20221231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 596145.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 1516199.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 1516199.0000 shares 3 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues -1516199.0000 shares 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 319207.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 39000.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 127000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Value 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20231231 Accounts Receivable Net Current 84000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Additional Paid In Capital 76733000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Additional Paid In Capital 86709000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Assets 2641000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Assets Noncurrent 386000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Common Stock Shares Issued 3678550.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Derivative Liabilities Current 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Foreign Currency Transaction Gain Loss Unrealized 11000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Impairment Of Intangible Assets Excluding Goodwill 874000.0000 USD 1 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Computer Software Intangible Asset;
0001437749-25-010818 20241231 Impairment Of Intangible Assets Excluding Goodwill 874000.0000 USD 4 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Computer Software Intangible Asset;
0001437749-25-010818 20241231 Increase Decrease In Accrued Liabilities -341000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Interest Paid Net 11000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Issuance Of Stock And Warrants For Services Or Claims 127000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Liabilities Current 2532000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Liabilities Current 4976000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Net Cash Provided By Used In Financing Activities 6299000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Net Income Loss -10460000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Nonoperating Income Expense -404000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Other Nonoperating Income Expense 457000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Payments To Acquire Machinery And Equipment 148000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Proceeds From Issuance Of Common And Preferred Stock Net Of Issuance Costs 4308000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Proceeds From Warrant Exercises 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Proceeds From Warrant Exercises 36000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Research And Development Expense 1954000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Shares Outstanding 1516199.0000 shares 0 us-gaap/2024 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20221231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stockholders Equity -375000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 0.0000 shares 4 0001437749-25-010818 Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 127000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 1902000.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 133000.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 945000.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Shares 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Unrealized Gain Loss On Derivatives 157000.0000 USD 4 us-gaap/2024 Derivative Instrument Risk= Conversion Option;
0001437749-25-016587 20241231 Accounts Receivable Net Current 121000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Accrued Liabilities Current 1626000.0000 USD 0 us-gaap/2025 Related Party Transactions By Related Party= Related Party;
0001437749-25-016587 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -505000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Contract With Customer Liability Current 13000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Convertible Debt Current 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Deemed Dividend Warrant Inducement -4410000.0000 USD 1 0001437749-25-016587 Equity Components= Retained Earnings;
0001437749-25-016587 20240331 Gains Losses On Extinguishment Of Debt 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250131 Gains Losses On Extinguishment Of Debt -1353000.0000 USD 0 us-gaap/2025 Debt Conversion By Unique Description= Conversion Of Promissory Note To Common Stock;
0001437749-25-016587 20250331 Increase Decrease In Accounts Payable Trade -204000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Increase Decrease In Accounts Receivable 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Increase Decrease In Contract With Customer Liability 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Increase Decrease In Contract With Customer Liability -13000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 124000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Investment Income Net -128000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Issuance Of Stock And Warrants For Services Or Claims 32000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Liabilities Current 7178000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Net Cash Provided By Used In Investing Activities -7000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Net Income Loss Available To Common Stockholders Basic -17340000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250131 Proceeds From Warrant Exercises 5625000.0000 USD 0 us-gaap/2025 Class Of Warrant Or Right= P I P E Warrants;
0001437749-25-016587 20250331 Proceeds From Warrant Exercises 8828000.0000 USD 1 us-gaap/2025 Class Of Warrant Or Right= Warrants And Penny Warrants;
0001437749-25-016587 20250331 Selling And Marketing Expense 208000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20241231 Stockholders Equity 86709000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Stock Issued During Period Shares Conversion Of Convertible Securities 800000000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20250331 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares Issued For Services 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares New Issues 547737.0000 shares 0 us-gaap/2025 Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250430 Stock Issued During Period Shares New Issues 21000.0000 shares 0 us-gaap/2025 Counterparty Name= Former Employee; Subsequent Event Type= Subsequent Event;
0001437749-25-016587 20250331 Stock Issued During Period Shares Warrant Exercises 2186595.0000 shares 1 0001437749-25-016587 Equity Components= Common Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Issued For Services 32000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20240331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value New Issues 1464000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20240331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Accrued Liabilities Current 1156000.0000 USD 0 us-gaap/2025 Related Party Transactions By Related Party= Related Party;
0001437749-25-016587 20241231 Additional Paid In Capital 86709000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Assets 12363000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Assets Noncurrent 1986000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0001437749-25-016587 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Convertible Debt Current 694000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Debt Conversion Converted Instrument Amount1 12339000.0000 USD 1 us-gaap/2025 Debt Conversion By Unique Description= Conversion Of Promissory Note To Common Stock;
0001437749-25-016587 20250331 Earnings Per Share Basic -1.7400 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Foreign Currency Transaction Gain Loss Unrealized 3000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Increase Decrease In Accrued Liabilities -603000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Investment Income Net -2000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Net Cash Provided By Used In Financing Activities 945000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Net Cash Provided By Used In Financing Activities 10253000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Net Income Loss -12930000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 60000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Nonoperating Income Expense -10865000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Other Nonoperating Income Expense -1000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Payments To Acquire Machinery And Equipment 7000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20231231 Stockholders Equity -76624000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20241231 Stockholders Equity -375000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250228 Stock Issued During Period Shares New Issues 15000.0000 shares 0 us-gaap/2025 Related Party Transactions By Related Party= Officer;
0001437749-25-016587 20250331 Stock Issued During Period Shares New Issues 547737.0000 shares 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Share Based Compensation Gross 247000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Warrant Exercises 0.0000 USD 1 0001437749-25-016587 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Assets Noncurrent 1973000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Accrued Liabilities Current 1626000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001437749-25-010818 20241231 Adjustments To Additional Paid In Capital Warrant Issued 636000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Adjustments To Additional Paid In Capital Warrant Issued 636000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Adjustments To Additional Paid In Capital Warrant Issued 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Adjustments To Additional Paid In Capital Warrant Issued 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Assets 4601000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Assets Current 2628000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Contract With Customer Liability Current 13000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Depreciation Depletion And Amortization 67000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Income Tax Expense Benefit 1000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Increase Decrease In Accounts Payable 883000.0000 USD 4 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001437749-25-010818 20241231 Increase Decrease In Accounts Payable 0.0000 USD 4 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001437749-25-010818 20231231 Increase Decrease In Contract With Customer Liability -909000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets -30000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Income Loss -2603000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20231231 Other Noncash Income Expense 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Prepaid Expense And Other Assets Current 697000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Proceeds From Convertible Debt 1955000.0000 USD 4 us-gaap/2024 Debt Instrument= Convertible Promissory Note;
0001437749-25-010818 20231231 Property Plant And Equipment Net 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Revenue From Contract With Customer Including Assessed Tax 108000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Revenue From Contract With Customer Including Assessed Tax 0.0000 USD 4 us-gaap/2024 Counterparty Name= Israeli Innovation Authority I I A; Product Or Service= Grant;
0001437749-25-010818 20221231 Shares Outstanding 265485.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20221231 Stockholders Equity 71195000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities -1516199.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 22344.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 698181.0000 shares 4 0001437749-25-010818 Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 2440000.0000 USD 4 us-gaap/2024 Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 2608000.0000 USD 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 3363000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Value Share Based Compensation Gross 295000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Share Based Compensation Gross 2594000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Shares 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Unrealized Gain Loss On Derivatives -156000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Weighted Average Number Of Shares Outstanding Basic 6546769.0000 shares 4 us-gaap/2024
0001437749-25-010818 20231231 Accounts Payable Current 630000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Adjustments To Additional Paid In Capital Warrant Issued 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20231231 Assets Current 2255000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Cash 2143000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001437749-25-010818 20231231 General And Administrative Expense 2196000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Increase Decrease In Accounts Receivable 37000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Increase Decrease In Accrued Liabilities 1047000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Liabilities 4976000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Net Cash Provided By Used In Operating Activities -2172000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20231231 Nonoperating Income Expense 476000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Operating Expenses 10162000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Prepaid Expense And Other Assets Current 28000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Proceeds From Convertible Debt 1955000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20250131 Proceeds From Warrant Exercises 5625000.0000 USD 0 us-gaap/2024 Class Of Warrant Or Right= Prefunded Warrant And P I P E Warrant; Subsequent Event Type= Subsequent Event;
0001437749-25-010818 20241231 Product Enhancements Intangible Asset 206000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Revenue From Contract With Customer Including Assessed Tax 498000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Selling And Marketing Expense 1201000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Share Based Compensation 295000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Shares Outstanding 3678550.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20221231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20231231 Stockholders Equity -76624000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities -246919.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities -1516199.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20230430 Stock Issued During Period Shares Issued For Services 29636.0000 shares 0 us-gaap/2024 Related Party Transaction= Consulting Fees; Related Party Transactions By Related Party= Executive Officer;
0001437749-25-010818 20230228 Stock Issued During Period Shares New Issues 3383784.0000 shares 0 us-gaap/2024 Subsidiary Sale Of Stock= Securities Purchase Agreement;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 159966.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 86953.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 1902000.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 945000.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 36000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20241231 Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 36000.0000 USD 4 0001437749-25-010818 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 0.0000 USD 4 0001437749-25-010818 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Shares 439.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Accounts Payable Current 1816000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Accounts Receivable Net Current 121000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Cash 1810000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001437749-25-010818 20241231 Common Stock Shares Issued 8122060.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Deemed Issuance Of Common Shares 0.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Depreciation Depletion And Amortization 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Foreign Currency Transaction Gain Loss Unrealized 37000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Impairment Of Intangible Assets Excluding Goodwill 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Investment Income Net -69000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Liabilities And Stockholders Equity 4601000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Net Cash Provided By Used In Investing Activities -477000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Income Loss -2603000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20231231 Payments To Acquire Businesses Net Of Cash Acquired 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Payments To Acquire Machinery And Equipment 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Preferred Stock Shares Authorized 1000000.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Preferred Stock Shares Outstanding 1676165.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Proceeds From Issuance Of Common And Preferred Stock Net Of Issuance Costs 4643000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20241231 Proceeds From Warrant Exercises 36.0000 USD 4 us-gaap/2024 Class Of Warrant Or Right= Tranche A Warrants Series A Warrants And Series D Warrants;
0001437749-25-010818 20231231 Product Enhancements Intangible Asset USD 4 0001437749-25-010818
0001437749-25-010818 20231231 Shares Outstanding 1676165.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20240731 Shares Outstanding 802142.0000 shares 0 us-gaap/2024 Counterparty Name= Former Shareholders Of Wavedancer;
0001437749-25-010818 20241231 Shares Outstanding 8122060.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20230430 Stock Issued During Period Shares Issued For Services 29636.0000 shares 0 us-gaap/2024 Related Party Transaction= Consulting Fees; Related Party Transactions By Related Party= Related Party;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 1516199.0000 shares 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 39000.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 3363000.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Value Share Based Compensation Gross 295000.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 0.0000 USD 4 0001437749-25-010818 Equity Components= Retained Earnings;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Shares 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Value 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Accrued Liabilities Current 1902000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001437749-25-010818 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2143000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 2085000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Derivative Liabilities Current 827000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 General And Administrative Expense 6133000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -10458000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Increase Decrease In Accounts Payable -2000.0000 USD 4 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001437749-25-010818 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets 73000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Operating Income Loss -3078000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Operating Income Loss -10054000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Other Nonoperating Income Expense -190000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Payments To Acquire Businesses Net Of Cash Acquired 62000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Prepaid Expense And Other Assets Noncurrent 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Proceeds From Convertible Debt 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20250228 Proceeds From Warrant Exercises 3200000.0000 USD 0 us-gaap/2024 Class Of Warrant Or Right= Convertible Promissory Note Warrants; Subsequent Event Type= Subsequent Event;
0001437749-25-010818 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20221231 Stockholders Equity -2226000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Stockholders Equity 109000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Stockholders Equity 76733000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stockholders Equity 86709000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20231231 Stock Issued1 0.0000 USD 4 us-gaap/2024 Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 802142.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 45344.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20230228 Stock Issued During Period Shares New Issues 1123110.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 1516199.0000 shares 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 3383784.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock; Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 2440000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 133000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20231231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Share Based Compensation Gross 2594000.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Value 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1810000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Common Stock Shares Outstanding 3678550.0000 shares 0 us-gaap/2024
0001437749-25-010818 20241231 Debt Conversion Converted Instrument Amount1 39000.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock;
0001437749-25-010818 20231231 Earnings Per Share Basic -0.8100 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Income Tax Expense Benefit 2000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Intangible Assets Net Excluding Goodwill 386000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Intangible Assets Net Excluding Goodwill 180000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Interest Paid Net 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Liabilities 2532000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Liabilities And Stockholders Equity 2641000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Payments For Product Enhancements 267000.0000 USD 4 0001437749-25-010818
0001437749-25-010818 20241231 Property Plant And Equipment Net 136000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Retained Earnings Accumulated Deficit -76624000.0000 USD 0 us-gaap/2024
0001437749-25-010818 20231231 Revenue From Contract With Customer Including Assessed Tax 0.0000 USD 4 us-gaap/2024 Counterparty Name= Israeli Innovation Authority I I A; Product Or Service= Grant;
0001437749-25-010818 20221231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20231231 Shares Outstanding -1516199.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued1 2440000.0000 USD 4 us-gaap/2024 Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 10588.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Conversion Of Debt Into Common Stock; Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 433360.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Common Stock Private Placement;
0001437749-25-010818 20240731 Stock Issued During Period Shares New Issues 319207.0000 shares 0 us-gaap/2024 Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20241231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 0.0000 shares 4 0001437749-25-010818 Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities -204000.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20231231 Stock Issued During Period Value New Issues 2608000.0000 USD 4 us-gaap/2024 Class Of Stock= Series B Preferred Stock; Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Series B Preferred Stock Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Common Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 0.0000 USD 4 0001437749-25-010818 Equity Components= Common Stock;
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Value 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Stock Repurchased And Retired During Period Value 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001437749-25-010818 20231231 Unrealized Gain Loss On Derivatives 0.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Weighted Average Number Of Shares Outstanding Basic 3233270.0000 shares 4 us-gaap/2024
0001437749-25-016587 20250331 Assets Current 10377000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1638000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Deemed Dividend Liability Current 4410000.0000 USD 0 0001437749-25-016587
0001437749-25-016587 20240331 Depreciation Depletion And Amortization 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Drawdown In Shares Issued For Prepaid Services 63000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20240331 Foreign Currency Transaction Gain Loss Unrealized -28000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Income Taxes Paid Net 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Income Tax Expense Benefit 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Intangible Assets Net Excluding Goodwill 170000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20240331 Net Income Loss -1122000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Operating Expenses 2108000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2025
0001437749-25-016587 20240331 Proceeds From Issuance Of Shares And Settlement Of Convertible Promissory Note Net Of Issuance Costs 945000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20241231 Property Plant And Equipment Net 136000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Research And Development Expense 289000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Research And Development Expense 312000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Retained Earnings Accumulated Deficit -104424000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Revenue From Contract With Customer Including Assessed Tax 43000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stockholders Equity -77746000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Unrealized Gain Loss On Derivatives -9369000.0000 USD 1 us-gaap/2025
0001437749-25-010818 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 58000.0000 USD 0 us-gaap/2024
0001437749-25-016587 20241231 Accounts Payable Current 1816000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Cash 9545000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250131 Deemed Dividend Liability Current 4410000.0000 USD 0 0001437749-25-016587
0001437749-25-016587 20250331 Deemed Dividend Warrant Inducement -4410000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20250331 Derivative Liabilities Current 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Interest Paid Net 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Noncash Transaction Deemed Dividend On Warrant Inducement 0.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20240331 Nonoperating Income Expense -31000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Operating Expenses 1103000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Operating Income Loss -2065000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Preferred Stock Shares Authorized 1000000.0000 shares 0 us-gaap/2025
0001437749-25-016587 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Prepaid Expense And Other Assets Current 732000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Prepaid Expense And Other Assets Noncurrent 1657000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Proceeds From Issuance Of Shares And Settlement Of Convertible Promissory Note Net Of Issuance Costs 1425000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20241231 Retained Earnings Accumulated Deficit -87084000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Revenue From Contract With Customer Including Assessed Tax 0.0000 USD 4 us-gaap/2025 Counterparty Name= Israeli Innovation Authority I I A; Product Or Service= Grant;
0001437749-25-016587 20231231 Shares Outstanding 3678550.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20231231 Shares Outstanding 1676165.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20241231 Shares Outstanding 8122060.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20250331 Shares Outstanding 11678736.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares Conversion Of Convertible Securities -1516199.0000 shares 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares Conversion Of Convertible Securities 1516199.0000 shares 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares Issued For Services 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20240331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Shares Warrant Exercises 2186595.0000 shares 1 0001437749-25-016587 Class Of Warrant Or Right= Warrants And Penny Warrants;
0001437749-25-016587 20250331 Stock Issued During Period Shares Warrant Exercises 0.0000 shares 1 0001437749-25-016587 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 12329000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 12329000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Stock Issued During Period Value Issued For Services 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Share Based Compensation Gross 247000.0000 USD 1 us-gaap/2025 Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20241231 Assets Current 2628000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025
0001437749-25-016587 20241231 Common Stock Shares Outstanding 8122060.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Common Stock Shares Outstanding 11678736.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Deemed Dividend Warrant Inducement 0.0000 USD 1 0001437749-25-016587 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1122000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -12930000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Increase Decrease In Accounts Payable Trade 357000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Increase Decrease In Accounts Receivable -21000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Increase Decrease In Accrued Liabilities -470000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Intangible Assets Net Excluding Goodwill 180000.0000 USD 0 us-gaap/2025 Finite Lived Intangible Assets By Major Class= Computer Software Intangible Asset;
0001437749-25-016587 20240331 Issuance Of Stock And Warrants For Services Or Claims 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Liabilities Current 4976000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Net Cash Provided By Used In Operating Activities -1319000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Noncash Transaction Deemed Dividend On Warrant Inducement 4410000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20240331 Payments To Acquire Machinery And Equipment 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Preferred Stock Shares Authorized 1000000.0000 shares 0 us-gaap/2025
0001437749-25-016587 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Prepaid Expense And Other Assets Current 697000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Proceeds From Warrant Exercises 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250131 Proceeds From Warrant Exercises 3200000.0000 USD 0 us-gaap/2025 Class Of Warrant Or Right= Convertible Promissory Note Warrants;
0001437749-25-016587 20240331 Revenue From Contract With Customer Including Assessed Tax 12000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20231231 Shares Outstanding 1516199.0000 shares 0 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20240331 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stockholders Equity 77737000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Series C Preferred Stock Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Issued For Services 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Warrant Exercises 0.0000 USD 1 0001437749-25-016587 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Weighted Average Number Of Shares Outstanding Basic 5194665.0000 shares 1 us-gaap/2025
0001437749-25-016587 20250331 Weighted Average Number Of Shares Outstanding Basic 9956933.0000 shares 1 us-gaap/2025
0001437749-25-016587 20241231 Cash 1810000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2143000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Common Stock Shares Issued 8122060.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Common Stock Shares Issued 11678736.0000 shares 0 us-gaap/2025
0001437749-25-016587 20250331 Deemed Dividend Warrant Inducement 0.0000 USD 1 0001437749-25-016587 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20240331 General And Administrative Expense 565000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 General And Administrative Expense 1588000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Income Taxes Paid Net 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Income Tax Expense Benefit 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Liabilities 4976000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Liabilities 7178000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Liabilities And Stockholders Equity 4601000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Net Cash Provided By Used In Investing Activities -131000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Net Income Loss -12930000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Other Nonoperating Income Expense -18000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Payments To Acquire Intangible Assets 131000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Payments To Acquire Intangible Assets 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Prepaid Expense And Other Assets Noncurrent 1682000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Share Based Compensation 59000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Shares Outstanding 0.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20231231 Stockholders Equity 109000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stockholders Equity 109608000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Stockholders Equity 1000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20250331 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares Issued For Services 22344.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares Warrant Exercises 0.0000 shares 1 0001437749-25-016587 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Additional Paid In Capital;
0001437749-25-016587 20240331 Stock Issued During Period Value New Issues 945000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Stock Issued During Period Value New Issues 945000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20250331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250331 Stock Issued During Period Value New Issues 1464000.0000 USD 1 us-gaap/2025 Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20240331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Value Share Based Compensation Gross 59000.0000 USD 1 us-gaap/2025 Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Warrant Exercises 1000.0000 USD 1 0001437749-25-016587 Equity Components= Common Stock;
0001437749-25-016587 20250331 Additional Paid In Capital 109608000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Amortization Of Financing Costs And Discounts 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1810000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 7735000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001437749-25-016587 20250331 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025
0001437749-25-016587 20241231 Common Stock Value 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Contract With Customer Liability Current 0.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Deemed Dividend Liability Current 0.0000 USD 0 0001437749-25-016587
0001437749-25-016587 20240331 Deemed Dividend Warrant Inducement 0.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20250331 Deemed Dividend Warrant Inducement 0.0000 USD 1 0001437749-25-016587 Equity Components= Common Stock;
0001437749-25-016587 20250331 Depreciation Depletion And Amortization 19000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Earnings Per Share Basic -0.2200 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets 10000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Net Income Loss -1122000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Operating Income Loss -1091000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Proceeds From Warrant Exercises 8828000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Revenue From Contract With Customer Including Assessed Tax 0.0000 USD 1 us-gaap/2025 Counterparty Name= Israeli Innovation Authority I I A; Product Or Service= Grant;
0001437749-25-016587 20231231 Shares Outstanding -1516199.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock To Be Issued;
0001437749-25-016587 20240331 Shares Outstanding 246965.0000 shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20231231 Stockholders Equity 76733000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20241231 Stockholders Equity -87084000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stockholders Equity 5185000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Stock Issued During Period Shares Conversion Of Convertible Securities 1516199.0000 shares 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares Conversion Of Convertible Securities -1516199.0000 shares 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Shares Conversion Of Convertible Securities 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stock Issued During Period Shares Issued For Services 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20240331 Stock Issued During Period Shares New Issues 86999.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Series C Preferred Stock Offering;
0001437749-25-016587 20240331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 1 us-gaap/2025 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Issued For Services 32000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Stock Issued During Period Value Share Based Compensation Gross 59000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20240331 Stock Issued During Period Value Share Based Compensation Gross 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-016587 20250331 Stock Issued During Period Value Warrant Exercises 8828000.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20250331 Accounts Receivable Net Current 100000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Amortization Of Financing Costs And Discounts 126000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Assets 4601000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20241231 Assets Noncurrent 1973000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 9545000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Common Stock Value 1000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Debt Conversion Converted Instrument Amount1 0.0000 USD 1 us-gaap/2025 Debt Conversion By Unique Description= Conversion Of Promissory Note To Common Stock;
0001437749-25-016587 20241231 Derivative Liabilities Current 827000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Drawdown In Shares Issued For Prepaid Services 0.0000 USD 1 0001437749-25-016587
0001437749-25-016587 20250331 Gains Losses On Extinguishment Of Debt -1353000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20241231 Intangible Assets Net Excluding Goodwill 180000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Intangible Assets Net Excluding Goodwill 170000.0000 USD 0 us-gaap/2025 Finite Lived Intangible Assets By Major Class= Computer Software Intangible Asset;
0001437749-25-016587 20240331 Interest Paid Net 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Liabilities And Stockholders Equity 12363000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Net Cash Provided By Used In Operating Activities -2511000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Net Income Loss Available To Common Stockholders Basic -1122000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 0.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Property Plant And Equipment Net 134000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20240331 Selling And Marketing Expense 249000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20250331 Share Based Compensation 247000.0000 USD 1 us-gaap/2025
0001437749-25-016587 20240331 Shares Outstanding 5194749.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-016587 20240331 Stockholders Equity -9000.0000 USD 0 us-gaap/2025
0001437749-25-016587 20250331 Stockholders Equity -104424000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-016587 20250331 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-016587 20250430 Stock Issued During Period Shares New Issues 340000.0000 shares 0 us-gaap/2025 Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= Inducement Agreement;
0001437749-25-016587 20250331 Stock Issued During Period Shares Warrant Exercises 0.0000 shares 1 0001437749-25-016587 Equity Components= Common Stock To Be Issued;
0001437749-25-016587 20250331 Stock Issued During Period Value Issued For Services 0.0000 USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001437749-25-016587 20250331 Stock Issued During Period Value Warrant Exercises 8827000.0000 USD 1 0001437749-25-016587 Equity Components= Additional Paid In Capital;
0001437749-25-016587 20240331 Unrealized Gain Loss On Derivatives 0.0000 USD 1 us-gaap/2025
0001437749-25-010818 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -333000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20240731 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024 Class Of Stock= Private Firefly;
0001437749-25-010818 20231231 Common Stock Value 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Common Stock Value 0.0000 USD 0 us-gaap/2024
0001437749-25-010818 20241231 Impairment Of Intangible Assets Excluding Goodwill 874000.0000 USD 1 us-gaap/2024
0001437749-25-010818 20241231 Impairment Of Intangible Assets Excluding Goodwill 874000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2602000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Increase Decrease In Accounts Payable 35000.0000 USD 4 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001437749-25-010818 20231231 Increase Decrease In Accounts Receivable 65000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Increase Decrease In Contract With Customer Liability 13000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Intangible Assets Net Excluding Goodwill 180000.0000 USD 0 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Computer Software Intangible Asset;
0001437749-25-010818 20231231 Net Cash Provided By Used In Financing Activities 4643000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Net Cash Provided By Used In Operating Activities -6155000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Net Income Loss -10460000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Operating Expenses 3576000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20241231 Other Noncash Income Expense -12000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20231231 Preferred Stock Shares Authorized 3120000.0000 shares 0 us-gaap/2024
0001437749-25-010818 20231231 Selling And Marketing Expense 639000.0000 USD 4 us-gaap/2024
0001437749-25-010818 20240731 Shares Outstanding 7472555.0000 shares 0 us-gaap/2024
0001437749-25-010818 20221231 Stockholders Equity -74021000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stockholders Equity -87084000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001437749-25-010818 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 1516199.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Conversion Of Series B Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Shares Issued For Services 0.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock To Be Issued; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20231231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares New Issues 0.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Preferred Stock; Equity Components= Preferred Stock To Be Issued; Subsidiary Sale Of Stock= Series C Preferred Stock Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares Share Based Compensation Gross 29636.0000 shares 4 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20231231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Share Based Compensation Gross 0.0000 shares 4 us-gaap/2024 Equity Components= Common Stock To Be Issued; Subsidiary Sale Of Stock= Units Offering;
0001437749-25-010818 20241231 Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 0.0000 shares 4 0001437749-25-010818 Equity Components= Common Stock To Be Issued;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities -204000.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Additional Paid In Capital;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series B Preferred Stock Into Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Conversion Of Stock By Unique Description= Conversion Of Series C Preferred Stock Into Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 0.0000 USD 4 us-gaap/2024 Debt Conversion By Unique Description= Future Settlement Of Debt Settled With Common Stock; Equity Components= Preferred Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock; Type Of Arrangement= Shares Issued For Prepaid Services;
0001437749-25-010818 20241231 Stock Issued During Period Value New Issues 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings; Subsidiary Sale Of Stock= Private Placement;
0001437749-25-010818 20231031 Stock Repurchased And Retired During Period Shares 355.0000 shares 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Increase Decrease In Contract With Customer Liability us-gaap/2025 0 0 monetary D D Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Prepaid Expense And Other Assets Noncurrent us-gaap/2025 0 0 monetary I D Prepaid Expense and Other Assets, Noncurrent Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 0 0 monetary D C Payments to Acquire Businesses, Net of Cash Acquired The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Convertible Debt Current us-gaap/2025 0 0 monetary I C Convertible Debt, Current The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Foreign Currency Transaction Gain Loss Unrealized us-gaap/2025 0 0 monetary D C Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of unrealized gain (loss) from foreign currency transaction.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Increase Decrease In Contract With Customer Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued1 us-gaap/2024 0 0 monetary D C Stock Issued The fair value of stock issued in noncash financing activities.
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Stock Issued During Period Value Share Based Compensation Gross us-gaap/2024 0 0 monetary D C Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Property Plant And Equipment Net us-gaap/2025 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
General And Administrative Expense us-gaap/2025 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Convertible Debt Current us-gaap/2024 0 0 monetary I C Convertible Debt, Current The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Derivative Liabilities Current us-gaap/2024 0 0 monetary I C Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Payments To Acquire Intangible Assets us-gaap/2025 0 0 monetary D C Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
Additional Paid In Capital us-gaap/2025 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Gains Losses On Extinguishment Of Debt us-gaap/2025 0 0 monetary D C Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
Unrealized Gain Loss On Derivatives us-gaap/2025 0 0 monetary D C Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.
Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 0001437749-25-010818 1 0 shares D Shares issued - stock options, warrants and RSU exercises (in shares) The stock issued during the period for the exercise of stock options, warrants, and RSUs.
Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 0001437749-25-010818 1 0 monetary D C Shares issued - stock options, warrants and RSU exercises Amount for shares of stock issued during period from the exercise of stock options, warrants, and RSUs.
Noncash Transaction Deemed Dividend On Warrant Inducement 0001437749-25-016587 1 0 monetary D C aiff_NoncashTransactionDeemedDividendOnWarrantInducement The amount of deemed dividend on warrant inducment as part of a noncash transaction.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Cash us-gaap/2024 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Debt Conversion Converted Instrument Amount1 us-gaap/2024 0 0 monetary D C Debt Conversion, Converted Instrument, Amount The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of unrealized gain (loss) from foreign currency transaction.
Impairment Of Intangible Assets Excluding Goodwill us-gaap/2024 0 0 monetary D D Impairment of Intangible Assets (Excluding Goodwill) The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Stock Repurchased And Retired During Period Shares us-gaap/2024 0 0 shares D Stock Repurchased and Retired During Period, Shares Number of shares that have been repurchased and retired during the period.
Depreciation Depletion And Amortization us-gaap/2025 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Intangible Assets Net Excluding Goodwill us-gaap/2025 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Operating Expenses us-gaap/2025 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Prepaid Expense And Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Noncurrent Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
Proceeds From Convertible Debt us-gaap/2024 0 0 monetary D D Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Increase Decrease In Accounts Payable Trade us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.
Operating Income Loss us-gaap/2025 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Research And Development Expense us-gaap/2025 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Value Issued For Services us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Accounts Receivable Net Current us-gaap/2025 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Selling And Marketing Expense us-gaap/2025 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Preferred Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Deemed Dividend Liability Current 0001437749-25-016587 1 0 monetary I C Deemed dividend liability The value of the current deemed dividend liability.
Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2024 0 0 shares D Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Stock Repurchased And Retired During Period Value us-gaap/2024 0 0 monetary D D Stock Repurchased and Retired During Period, Value Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).
Accrued Liabilities Current us-gaap/2025 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Shares Outstanding us-gaap/2025 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Contract With Customer Liability Current us-gaap/2025 0 0 monetary I C Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Payments To Acquire Machinery And Equipment us-gaap/2025 0 0 monetary D C Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Preferred Stock Shares Issued us-gaap/2025 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Stock Issued During Period Shares New Issues us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Stock Issued During Period Value Share Based Compensation Gross us-gaap/2025 0 0 monetary D C Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Liabilities Current us-gaap/2025 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Assets Noncurrent us-gaap/2025 0 0 monetary I D Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Investment Income Net us-gaap/2025 0 0 monetary D C Investment Income, Net Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.
Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Proceeds From Warrant Exercises us-gaap/2025 0 0 monetary D D Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants.
Stock Issued During Period Shares Issued For Services us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Interest And Bank Fees 0001437749-25-010818 1 0 monetary D D aiff_InterestAndBankFees Represents the amount of interest and bank fee expenses incurred during the period.
Proceeds From Issuance Of Common And Preferred Stock Net Of Issuance Costs 0001437749-25-010818 1 0 monetary D D Proceeds from sale of shares, net of issuance costs Amount of cash inflow from issuance of common and preferred stock, net of issuance costs.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Unrealized Gain Loss On Derivatives us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Increase Decrease In Accounts Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 us-gaap/2025 0 0 monetary D D Noncash or Part Noncash Acquisition, Fixed Assets Acquired The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Prepaid Expense And Other Assets Current us-gaap/2025 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Deemed Dividend Warrant Inducement 0001437749-25-016587 1 0 monetary D C Deemed dividend on warrant inducement The deemed dividend on the warrant inducement.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Assets Noncurrent us-gaap/2024 0 0 monetary I D Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Investment Income Net us-gaap/2024 0 0 monetary D C Investment Income, Net Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Payments To Acquire Machinery And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Assets Current us-gaap/2025 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Amortization Of Financing Costs And Discounts us-gaap/2025 0 0 monetary D D Amortization of Debt Issuance Costs and Discounts Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.
Cash us-gaap/2025 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Accrued Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Interest Paid Net us-gaap/2025 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activity Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Preferred Stock Shares Authorized us-gaap/2025 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2025 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Share Based Compensation us-gaap/2025 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Proceeds From Issuance Of Shares And Settlement Of Convertible Promissory Note Net Of Issuance Costs 0001437749-25-016587 1 0 monetary D D Proceeds from sale of shares (2025) and settlement of convertible promissory note (2024), net of issuance costs Amount of cash inflow from issuance of shares and the convertible promissory note.
Contract With Customer Liability Current us-gaap/2024 0 0 monetary I C Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Revenue From Contract With Customer Including Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Including Assessed Tax Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Accounts Payable Current us-gaap/2025 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Debt Conversion Converted Instrument Amount1 us-gaap/2025 0 0 monetary D C Debt Conversion, Converted Instrument, Amount The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Net Income Loss Available To Common Stockholders Basic us-gaap/2025 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Preferred Stock Value us-gaap/2025 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Revenue From Contract With Customer Including Assessed Tax us-gaap/2025 0 0 monetary D C Revenue from Contract with Customer, Including Assessed Tax Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Stock Issued During Period Shares Warrant Exercises 0001437749-25-016587 1 0 shares D Shares issued - warrants exercises (in shares) The number of shares issued during the period for warrant exercises.
Stock Issued During Period Value Warrant Exercises 0001437749-25-016587 1 0 monetary D C Shares issued - warrants exercises Value of stock issued during the period for warrant exercises.
Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 0 0 monetary D D Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
Proceeds From Warrant Exercises us-gaap/2024 0 0 monetary D D Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Taxes Paid Net us-gaap/2025 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Stock Issued During Period Value New Issues us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Derivative Liabilities Current us-gaap/2025 0 0 monetary I C Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
Issuance Of Stock And Warrants For Services Or Claims us-gaap/2025 0 0 monetary D D Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2025 0 0 shares D Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Deemed Issuance Of Common Shares 0001437749-25-010818 1 0 monetary D C Deemed issuance of shares to former shareholders of WaveDancer Amount of deemed issuance of common shares in noncash or part noncash transaction.
Payments For Product Enhancements 0001437749-25-010818 1 0 monetary D C aiff_PaymentsForProductEnhancements The amount paid for the purchase of product enhancements.
Product Enhancements Intangible Asset 0001437749-25-010818 1 0 monetary D C Product enhancements - intangible asset in accounts payable and accrued liabilities The amount of noncash enhancement on intangible assets products.
Drawdown In Shares Issued For Prepaid Services 0001437749-25-016587 1 0 monetary D D aiff_DrawdownInSharesIssuedForPrepaidServices The value for drawdown in shares for prepaid services.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001437749-25-010818 2 7 BS 0 H Cash us-gaap/2024 Cash 0
0001437749-25-010818 2 8 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001437749-25-010818 2 9 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and deposits 0
0001437749-25-010818 2 10 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001437749-25-010818 2 12 BS 0 H Prepaid Expense And Other Assets Noncurrent us-gaap/2024 Prepaid expenses and deposits 0
0001437749-25-010818 2 13 BS 0 H Property Plant And Equipment Net us-gaap/2024 Equipment, net 0
0001437749-25-010818 2 14 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangible assets, net 0
0001437749-25-010818 2 15 BS 0 H Assets Noncurrent us-gaap/2024 Total non current assets 0
0001437749-25-010818 2 16 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001437749-25-010818 2 18 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001437749-25-010818 2 19 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued liabilities 0
0001437749-25-010818 2 20 BS 0 H Contract With Customer Liability Current us-gaap/2024 Deferred revenue 0
0001437749-25-010818 2 21 BS 0 H Convertible Debt Current us-gaap/2024 Convertible promissory note, net of unamortized discount 0
0001437749-25-010818 2 22 BS 0 H Derivative Liabilities Current us-gaap/2024 Derivative liability 0
0001437749-25-010818 2 23 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001437749-25-010818 2 24 BS 0 H Liabilities us-gaap/2024 TOTAL LIABILITIES 0
0001437749-25-010818 2 25 BS 0 H Commitments And Contingencies us-gaap/2024 COMMITMENTS AND CONTINGENCIES (See Note 11) 0
0001437749-25-010818 2 27 BS 0 H Preferred Stock Value us-gaap/2024 Preferred shares, $0.0001 par value: 1,000,000 shares authorized 2024 3,120,000 shares authorized 2023 Nil and 1,676,165 issued and outstanding at December 31, 2024 and 2023, respectively 0
0001437749-25-010818 2 28 BS 0 H Common Stock Value us-gaap/2024 Common shares, $0.0001 par value: 100,000,000 shares authorized 2024 258,880,000 shares authorized 2023 8,122,060 and 3,678,550 issued and outstanding at December 31, 2024 and 2023, respectively 0
0001437749-25-010818 2 29 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001437749-25-010818 2 30 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001437749-25-010818 2 31 BS 0 H Stockholders Equity us-gaap/2024 TOTAL SHAREHOLDERS EQUITY (DEFICIT) 0
0001437749-25-010818 2 32 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY 0
0001437749-25-010818 3 3 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0001437749-25-010818 3 4 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, authorized (in shares) 0
0001437749-25-010818 3 5 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, issued (in shares) 0
0001437749-25-010818 3 6 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, outstanding (in shares) 0
0001437749-25-010818 3 7 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001437749-25-010818 3 8 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001437749-25-010818 3 9 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0001437749-25-010818 3 10 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding (in shares) 0
0001437749-25-010818 4 3 IS 0 H Revenue From Contract With Customer Including Assessed Tax us-gaap/2024 REVENUE 0
0001437749-25-010818 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development expenses 0
0001437749-25-010818 4 6 IS 0 H Selling And Marketing Expense us-gaap/2024 Selling and marketing expenses 0
0001437749-25-010818 4 7 IS 0 H General And Administrative Expense us-gaap/2024 General and administration expenses 0
0001437749-25-010818 4 8 IS 0 H Impairment Of Intangible Assets Excluding Goodwill us-gaap/2024 Impairment of intangible assets 0
0001437749-25-010818 4 9 IS 0 H Operating Expenses us-gaap/2024 TOTAL OPERATING EXPENSES 0
0001437749-25-010818 4 10 IS 0 H Operating Income Loss us-gaap/2024 OPERATING LOSS 0
0001437749-25-010818 4 12 IS 0 H Investment Income Net us-gaap/2024 Interest and bank fees 0
0001437749-25-010818 4 13 IS 0 H Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 Foreign exchange gain 0
0001437749-25-010818 4 14 IS 0 H Unrealized Gain Loss On Derivatives us-gaap/2024 Change in derivative fair value 0
0001437749-25-010818 4 15 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expenses) 0
0001437749-25-010818 4 16 IS 0 H Nonoperating Income Expense us-gaap/2024 TOTAL OTHER INCOME (EXPENSE) 0
0001437749-25-010818 4 17 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAX 0
0001437749-25-010818 4 18 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax provision 1
0001437749-25-010818 4 19 IS 0 H Net Income Loss us-gaap/2024 NET LOSS AND COMPREHENSIVE LOSS 0
0001437749-25-010818 4 20 IS 0 H Earnings Per Share Basic us-gaap/2024 BASIC AND DILUTED LOSS PER SHARE (in dollars per share) 0
0001437749-25-010818 4 21 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 0
0001437749-25-010818 5 34 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE (in shares) 0
0001437749-25-010818 5 35 EQ 0 H Stockholders Equity us-gaap/2024 BALANCE 0
0001437749-25-010818 5 36 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Shares issued for offering (in shares) 0
0001437749-25-010818 5 37 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Shares issued for offering 0
0001437749-25-010818 5 38 EQ 0 H Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2024 Share-based compensation expense (in shares) 0
0001437749-25-010818 5 39 EQ 0 H Stock Issued During Period Value Share Based Compensation Gross us-gaap/2024 Share-based compensation expense 0
0001437749-25-010818 5 40 EQ 0 H Stock Repurchased And Retired During Period Shares us-gaap/2024 Shares repurchase (in shares) 1
0001437749-25-010818 5 41 EQ 0 H Stock Repurchased And Retired During Period Value us-gaap/2024 Shares repurchase 0
0001437749-25-010818 5 42 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001437749-25-010818 5 43 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Shares issued for conversion (in shares) 0
0001437749-25-010818 5 44 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Shares issued for conversion 0
0001437749-25-010818 5 45 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Shares and warrants issued for consulting services (in shares) 0
0001437749-25-010818 5 46 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Shares and warrants issued for consulting services 0
0001437749-25-010818 5 47 EQ 0 H Stock Issued During Period Shares Stock Option Warrant And Rsu Exercises 0001437749-25-010818 Shares issued - stock options, warrants and RSU exercises (in shares) 0
0001437749-25-010818 5 48 EQ 0 H Stock Issued During Period Value Stock Option Warrant And Rsu Exercises 0001437749-25-010818 Shares issued - stock options, warrants and RSU exercises 0
0001437749-25-010818 5 49 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Warrants issued for convertible promissory note 0
0001437749-25-010818 5 50 EQ 0 H Shares Outstanding us-gaap/2024 BALANCE (in shares) 0
0001437749-25-010818 5 51 EQ 0 H Stockholders Equity us-gaap/2024 BALANCE 0
0001437749-25-010818 6 14 CF 0 H Net Income Loss us-gaap/2024 Net (loss) income 0
0001437749-25-010818 6 16 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001437749-25-010818 6 17 CF 0 H Interest And Bank Fees 0001437749-25-010818 Interest and bank fees 0
0001437749-25-010818 6 18 CF 0 H Unrealized Gain Loss On Derivatives us-gaap/2024 Change in derivative fair value 1
0001437749-25-010818 6 19 CF 0 H Impairment Of Intangible Assets Excluding Goodwill us-gaap/2024 Impairment of intangible assets 0
0001437749-25-010818 6 20 CF 0 H Other Noncash Income Expense us-gaap/2024 Other income (expenses) 1
0001437749-25-010818 6 21 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation expense 0
0001437749-25-010818 6 22 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 Shares and warrants issued for consulting services 0
0001437749-25-010818 6 24 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Change in accounts receivable 1
0001437749-25-010818 6 25 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Change in prepaid expenses and deposits 1
0001437749-25-010818 6 26 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Change in accounts payable 0
0001437749-25-010818 6 27 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Change in accrued liabilities 0
0001437749-25-010818 6 28 CF 0 H Increase Decrease In Contract With Customer Liability us-gaap/2024 Change in deferred revenue 0
0001437749-25-010818 6 29 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001437749-25-010818 6 31 CF 0 H Payments To Acquire Machinery And Equipment us-gaap/2024 Payments to acquire equipment 1
0001437749-25-010818 6 32 CF 0 H Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 Outflow from recapitalization transaction 1
0001437749-25-010818 6 33 CF 0 H Payments For Product Enhancements 0001437749-25-010818 Product enhancements intangible asset 1
0001437749-25-010818 6 34 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001437749-25-010818 6 36 CF 0 H Proceeds From Convertible Debt us-gaap/2024 Proceeds from issuance of convertible promissory note, net of transaction costs 0
0001437749-25-010818 6 37 CF 0 H Proceeds From Warrant Exercises us-gaap/2024 Proceeds from exercise of warrants 0
0001437749-25-010818 6 38 CF 0 H Proceeds From Issuance Of Common And Preferred Stock Net Of Issuance Costs 0001437749-25-010818 Proceeds from sale of shares, net of issuance costs 0
0001437749-25-010818 6 39 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001437749-25-010818 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 INCREASE (DECREASE) IN CASH 0
0001437749-25-010818 6 41 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 BALANCE OF CASH AT THE BEGINNING OF YEAR 0
0001437749-25-010818 6 42 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 BALANCE OF CASH AT THE END OF YEAR 0
0001437749-25-010818 6 44 CF 0 H Interest Paid Net us-gaap/2024 Cash paid for interest 0
0001437749-25-010818 6 45 CF 0 H Income Taxes Paid Net us-gaap/2024 Cash paid for income taxes 0
0001437749-25-010818 6 47 CF 0 H Deemed Issuance Of Common Shares 0001437749-25-010818 Deemed issuance of shares to former shareholders of WaveDancer 0
0001437749-25-010818 6 48 CF 0 H Product Enhancements Intangible Asset 0001437749-25-010818 Product enhancements - intangible asset in accounts payable and accrued liabilities 0
0001437749-25-010818 6 49 CF 0 H Stock Issued1 us-gaap/2024 Shares issued for prepaid services 0
0001437749-25-010818 6 50 CF 0 H Debt Conversion Converted Instrument Amount1 us-gaap/2024 Shares issued for debt 0
0001437749-25-016587 2 7 BS 0 H Cash us-gaap/2025 Cash 0
0001437749-25-016587 2 8 BS 0 H Accounts Receivable Net Current us-gaap/2025 Accounts receivable, net 0
0001437749-25-016587 2 9 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2025 Prepaid expenses and deposits 0
0001437749-25-016587 2 10 BS 0 H Assets Current us-gaap/2025 Total current assets 0
0001437749-25-016587 2 12 BS 0 H Prepaid Expense And Other Assets Noncurrent us-gaap/2025 Prepaid expenses and deposits 0
0001437749-25-016587 2 13 BS 0 H Property Plant And Equipment Net us-gaap/2025 Equipment, net 0
0001437749-25-016587 2 14 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2025 Intangible assets, net 0
0001437749-25-016587 2 15 BS 0 H Assets Noncurrent us-gaap/2025 Total non current assets 0
0001437749-25-016587 2 16 BS 0 H Assets us-gaap/2025 TOTAL ASSETS 0
0001437749-25-016587 2 18 BS 0 H Accounts Payable Current us-gaap/2025 Accounts payable 0
0001437749-25-016587 2 19 BS 0 H Accrued Liabilities Current us-gaap/2025 Accrued liabilities 0
0001437749-25-016587 2 20 BS 0 H Contract With Customer Liability Current us-gaap/2025 Deferred revenue 0
0001437749-25-016587 2 21 BS 0 H Convertible Debt Current us-gaap/2025 Convertible promissory note, net of unamortized discount 0
0001437749-25-016587 2 22 BS 0 H Deemed Dividend Liability Current 0001437749-25-016587 Deemed dividend liability 0
0001437749-25-016587 2 23 BS 0 H Derivative Liabilities Current us-gaap/2025 Derivative liability 0
0001437749-25-016587 2 24 BS 0 H Liabilities Current us-gaap/2025 Total current liabilities 0
0001437749-25-016587 2 25 BS 0 H Liabilities us-gaap/2025 TOTAL LIABILITIES 0
0001437749-25-016587 2 26 BS 0 H Commitments And Contingencies us-gaap/2025 COMMITMENTS AND CONTINGENCIES (Note 10) 0
0001437749-25-016587 2 28 BS 0 H Preferred Stock Value us-gaap/2025 Preferred shares, $0.0001 par value: 1,000,000 shares authorized - 2025; 1,000,000 shares authorized - 2024; nil issued and outstanding at March 31, 2025 and December 31, 2024 0
0001437749-25-016587 2 29 BS 0 H Common Stock Value us-gaap/2025 Common shares, $0.0001 par value: 100,000,000 shares authorized; 11,678,736 and 8,122,060 issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0001437749-25-016587 2 30 BS 0 H Additional Paid In Capital us-gaap/2025 Additional paid-in capital 0
0001437749-25-016587 2 31 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Accumulated deficit 0
0001437749-25-016587 2 32 BS 0 H Stockholders Equity us-gaap/2025 TOTAL SHAREHOLDERS EQUITY (DEFICIT) 0
0001437749-25-016587 2 33 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY 0
0001437749-25-016587 3 3 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2025 Preferred stock, par value (in dollars per share) 0
0001437749-25-016587 3 4 BS 1 H Preferred Stock Shares Authorized us-gaap/2025 Preferred stock, authorized (in shares) 0
0001437749-25-016587 3 5 BS 1 H Preferred Stock Shares Issued us-gaap/2025 Preferred stock, issued (in shares) 0
0001437749-25-016587 3 6 BS 1 H Preferred Stock Shares Outstanding us-gaap/2025 Preferred stock, outstanding (in shares) 0
0001437749-25-016587 3 7 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in dollars per share) 0
0001437749-25-016587 3 8 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, authorized (in shares) 0
0001437749-25-016587 3 9 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, issued (in shares) 0
0001437749-25-016587 3 10 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, outstanding (in shares) 0
0001437749-25-016587 4 3 IS 0 H Revenue From Contract With Customer Including Assessed Tax us-gaap/2025 REVENUE 0
0001437749-25-016587 4 5 IS 0 H Research And Development Expense us-gaap/2025 Research and development expenses 0
0001437749-25-016587 4 6 IS 0 H Selling And Marketing Expense us-gaap/2025 Selling and marketing expenses 0
0001437749-25-016587 4 7 IS 0 H General And Administrative Expense us-gaap/2025 General and administration expenses 0
0001437749-25-016587 4 8 IS 0 H Operating Expenses us-gaap/2025 TOTAL OPERATING EXPENSES 0
0001437749-25-016587 4 9 IS 0 H Operating Income Loss us-gaap/2025 OPERATING LOSS 0
0001437749-25-016587 4 11 IS 0 H Investment Income Net us-gaap/2025 Interest and bank fees 0
0001437749-25-016587 4 12 IS 0 H Foreign Currency Transaction Gain Loss Unrealized us-gaap/2025 Unrealized gain (loss) on foreign exchange 0
0001437749-25-016587 4 13 IS 0 H Unrealized Gain Loss On Derivatives us-gaap/2025 Change in derivative fair value 0
0001437749-25-016587 4 14 IS 0 H Gains Losses On Extinguishment Of Debt us-gaap/2025 Loss on settlement of convertible promissory note 0
0001437749-25-016587 4 15 IS 0 H Other Nonoperating Income Expense us-gaap/2025 Other income (expense) 0
0001437749-25-016587 4 16 IS 0 H Nonoperating Income Expense us-gaap/2025 TOTAL OTHER INCOME (EXPENSE) 0
0001437749-25-016587 4 17 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 LOSS BEFORE INCOME TAX 0
0001437749-25-016587 4 18 IS 0 H Income Tax Expense Benefit us-gaap/2025 Income tax provision 1
0001437749-25-016587 4 19 IS 0 H Net Income Loss us-gaap/2025 NET LOSS AND COMPREHENSIVE LOSS 0
0001437749-25-016587 4 20 IS 0 H Deemed Dividend Warrant Inducement 0001437749-25-016587 Deemed dividend on warrant inducement 0
0001437749-25-016587 4 21 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2025 NET LOSS AND COMPREHENSIVE LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 0
0001437749-25-016587 4 22 IS 0 H Earnings Per Share Basic us-gaap/2025 BASIC AND DILUTED LOSS PER SHARE (in dollars per share) 0
0001437749-25-016587 4 23 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 0
0001437749-25-016587 5 19 EQ 0 H Shares Outstanding us-gaap/2025 BALANCE (in shares) 0
0001437749-25-016587 5 20 EQ 0 H Stockholders Equity us-gaap/2025 BALANCE 0
0001437749-25-016587 5 21 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2025 Shares issued for offering (in shares) 0
0001437749-25-016587 5 22 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2025 Shares issued for offering 0
0001437749-25-016587 5 23 EQ 0 H Stock Issued During Period Shares Warrant Exercises 0001437749-25-016587 Shares issued - warrants exercises (in shares) 0
0001437749-25-016587 5 24 EQ 0 H Stock Issued During Period Value Warrant Exercises 0001437749-25-016587 Shares issued - warrants exercises 0
0001437749-25-016587 5 25 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2025 Shares issued for conversion of Convertible Promissory Note (in shares) 0
0001437749-25-016587 5 26 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2025 Shares issued for conversion of Convertible Promissory Note 0
0001437749-25-016587 5 27 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2025 Shares issued for consulting services (in shares) 0
0001437749-25-016587 5 28 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2025 Shares issued for consulting services 0
0001437749-25-016587 5 29 EQ 0 H Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2025 Share-based compensation expense (in shares) 0
0001437749-25-016587 5 30 EQ 0 H Stock Issued During Period Value Share Based Compensation Gross us-gaap/2025 Share-based compensation expense 0
0001437749-25-016587 5 31 EQ 0 H Deemed Dividend Warrant Inducement 0001437749-25-016587 Deemed dividend on warrant inducement 0
0001437749-25-016587 5 32 EQ 0 H Net Income Loss us-gaap/2025 Net loss 0
0001437749-25-016587 5 33 EQ 0 H Shares Outstanding us-gaap/2025 BALANCE (in shares) 0
0001437749-25-016587 5 34 EQ 0 H Stockholders Equity us-gaap/2025 BALANCE 0
0001437749-25-016587 6 7 CF 0 H Net Income Loss us-gaap/2025 Net (loss) income 0
0001437749-25-016587 6 9 CF 0 H Depreciation Depletion And Amortization us-gaap/2025 Depreciation and amortization 0
0001437749-25-016587 6 10 CF 0 H Share Based Compensation us-gaap/2025 Share-based compensation expense 0
0001437749-25-016587 6 11 CF 0 H Amortization Of Financing Costs And Discounts us-gaap/2025 Accretion expense on convertible promissory note 0
0001437749-25-016587 6 12 CF 0 H Unrealized Gain Loss On Derivatives us-gaap/2025 Change in derivative fair value 1
0001437749-25-016587 6 13 CF 0 H Gains Losses On Extinguishment Of Debt us-gaap/2025 Loss on settlement of convertible promissory note 1
0001437749-25-016587 6 14 CF 0 H Drawdown In Shares Issued For Prepaid Services 0001437749-25-016587 Drawdown in shares issued for prepaid services 0
0001437749-25-016587 6 15 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2025 Shares issued for consulting services 0
0001437749-25-016587 6 17 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2025 Change in accounts receivable, net 1
0001437749-25-016587 6 18 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 Change in prepaid expenses and deposits 1
0001437749-25-016587 6 19 CF 0 H Increase Decrease In Accounts Payable Trade us-gaap/2025 Change in trade payables 0
0001437749-25-016587 6 20 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2025 Change in accrued liabilities 0
0001437749-25-016587 6 21 CF 0 H Increase Decrease In Contract With Customer Liability us-gaap/2025 Change in deferred revenue 0
0001437749-25-016587 6 22 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash used in operating activities 0
0001437749-25-016587 6 24 CF 0 H Payments To Acquire Machinery And Equipment us-gaap/2025 Payments to acquire equipment 1
0001437749-25-016587 6 25 CF 0 H Payments To Acquire Intangible Assets us-gaap/2025 Product enhancement intangible asset 1
0001437749-25-016587 6 26 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash used in investing activities 0
0001437749-25-016587 6 28 CF 0 H Proceeds From Issuance Of Shares And Settlement Of Convertible Promissory Note Net Of Issuance Costs 0001437749-25-016587 Proceeds from sale of shares (2025) and settlement of convertible promissory note (2024), net of issuance costs 0
0001437749-25-016587 6 29 CF 0 H Proceeds From Warrant Exercises us-gaap/2025 Proceeds from warrants exercises 0
0001437749-25-016587 6 30 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash provided by financing activities 0
0001437749-25-016587 6 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 INCREASE (DECREASE) IN CASH 0
0001437749-25-016587 6 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 BALANCE OF CASH AT THE BEGINNING OF PERIOD 0
0001437749-25-016587 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 BALANCE OF CASH AT THE END OF PERIOD 0
0001437749-25-016587 6 35 CF 0 H Interest Paid Net us-gaap/2025 Cash paid for interest 0
0001437749-25-016587 6 36 CF 0 H Income Taxes Paid Net us-gaap/2025 Cash paid for income taxes 0
0001437749-25-016587 6 38 CF 0 H Debt Conversion Converted Instrument Amount1 us-gaap/2025 Shares issued for conversion of Convertible Promissory Note 0
0001437749-25-016587 6 39 CF 0 H Noncash Transaction Deemed Dividend On Warrant Inducement 0001437749-25-016587 Deemed dividend on warrant inducement 0
0001437749-25-016587 6 40 CF 0 H Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 us-gaap/2025 Non-cash acquisition of equipment 1

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.